#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Peripheral T-cell lymphoma unspecified Emphysema Subdural haematoma Transitional cell cancer of the renal pelvis and ureter Microscopic polyangiitis Ovarian cancer stage III Hepatocellular carcinoma Extranodal marginal zone B-cell lymphoma (MALT type) Breast angiosarcoma Mitochondrial encephalomyopathy Pyoderma gangrenosum Sarcoma Glomerulonephritis membranous Malignant melanoma Cholangitis sclerosing More trials…

    Learn about Rare Diseases

    Basal cell naevus syndrome Cytokine release syndrome Hereditary neuropathic amyloidosis – Diagnostics Pulmonary sarcoidosis Primary immunodeficiency syndrome Isodicentric chromosome 15 syndrome – Life with Disease Epidermolysis bullosa – Trials in Disease Primary mediastinal large B-cell lymphoma – Basic Information Small intestine leiomyosarcoma Glomerulonephritis rapidly progressive – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Carcik-Cd19 Cells Human Plasma Protein Dexmedetomidine Hydrochloride Vildagliptin Isoniazid 177Lu-Rhpsma-10.1 Trimetazidine Dihydrochloride Indometacin Piromelatine Ribonucleic Acid K30 Metformin Embonate 12 Grass Pollen Mixture LVT-001 Ruxotemitide TTX-381 Imifoplatin Magnesium Isosorbide Dinitrate Anastrozole Levetiracetam More therapies…

    Learn about Your Condition

    HER2 positive gastric cancer Large cell lung cancer stage 0 Diminished ovarian reserve Cervical dysplasia Affective disorder Atrophic vulvovaginitis Encephalitis autoimmune Supranuclear palsy Fragile X syndrome Breast cancer stage III Hyperparathyroidism primary Testicular germ cell tumour Type IIa hyperlipidaemia Orthostatic hypotension Conjunctivitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

    Recruiting

    3 1
    Investigated Drugs:
    • ZILEBESIRAN
    Austria Belgium Bulgaria Czechia Denmark France +11

  • A Study of Ferric Carboxymaltose to Improve Exercise Ability in Patients with Pulmonary Hypertension and Iron Deficiency

    Recruiting

    3 1 1
    Investigated Diseases:
    • Iron deficiency
    • Pulmonary hypertension
    Investigated Drugs:
    • Ferric Carboxymaltose
    • Sodium Chloride
    Belgium

  • A Study of Emrusolmin Safety and Effectiveness in Adults with Multiple System Atrophy, a Brain and Nerve Disorder

    Recruiting

    2 1 1
    Investigated Diseases:
    • Multiple system atrophy
    Investigated Drugs:
    • Emrusolmin
    France Germany Italy Spain

  • A Study of Povetacicept Compared to Tacrolimus for Adults with Primary Membranous Nephropathy

    Recruiting

    4 1 1
    Investigated Drugs:
    • Povetacicept
    • Tacrolimus
    Czechia Germany Hungary Ireland Italy The Netherlands +1

  • Long-term Safety Study of Vusolimogene Oderparepvec, RP2, and RP3 in Patients with Melanoma, Liver Cancer, or Advanced Solid Tumors

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    • Malignant melanoma
    • Metastatic malignant melanoma
    Investigated Drugs:
    • Vusolimogene Oderparepvec
    • RP2
    • RP3
    France Germany Greece Poland Spain

  • A Study Comparing Two Treatment Schedules of Venetoclax and Azacitidine in Adults with Newly Diagnosed Acute Myeloid Leukemia Not Suitable for Intensive Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Azacitidine
    • Venetoclax
    France Spain
Previous Page
1 … 87 88 89 90 91 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!